Lantheus experiences net loss in Q4, full fiscal year
A slight increase in revenue for the fourth quarter wasn't enough to offse...Read more on AuntMinnie.comRelated Reading:
Lantheus touts ASCO GU talks with PSMA agent
Lantheus submits drug master file for imaging biomarker
Point Biopharma to use Lantheus' PyL in clinical trial
Lantheus divests Puerto Rico nuclear medicine businesses
FDA clears Lantheus' AI bone software
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news